1,400 ViewsCRISPR Therapeutics AG, a gene-editing company, focuses on developing transformative gene-based medicines for the treatment of serious human diseases using its regularly interspaced short palindromic repeats associated protein-9 gene-editing platform in Switzerland. The crsp stock news at https://www.webull.com/quote/nasdaq-crsp has details regarding updates on the stock. Its lead product candidate is CTX001, an ex vivo […]
